BE Board:Industrial seminar series: Difference between revisions
No edit summary |
|||
| Line 5: | Line 5: | ||
September 23, 2005 - * Special Bioethics Seminar * | September 23, 2005 - * Special Bioethics Seminar * | ||
[http://www.holycross.edu/departments/philosophy/website/stempsey.htmlWilliam Stempsey (College of Holy Cross)] | |||
October 28, 2005 - * Special Bioethics Seminar * | October 28, 2005 - * Special Bioethics Seminar * | ||
Thomas Shannon (Worcester Polytechnic Institute) | [http://www.wpi.edu/Academics/Depts/HUA/People/shannon.html Thomas Shannon (Worcester Polytechnic Institute)] | ||
December 2, 2005 | December 2, 2005 | ||
Mark Trusheim (Massachusetts Biotechnology Council) | [http://www.massbio.org/ Mark Trusheim (Massachusetts Biotechnology Council)] | ||
==Past Speakers== | ==Past Speakers== | ||
Revision as of 10:19, 9 September 2005
Upcoming Speakers
September 23, 2005 - * Special Bioethics Seminar * Stempsey (College of Holy Cross)
October 28, 2005 - * Special Bioethics Seminar * Thomas Shannon (Worcester Polytechnic Institute)
December 2, 2005 Mark Trusheim (Massachusetts Biotechnology Council)
Past Speakers
- July 22, 2005
Dr. Paul Mason (Genzyme) "Drug discovery at Genzyme"
- June 10, 2005
Dr. Gyan Bhanot (IBM Life Sciences) "Systems biology and supercomputing at IBM Life Sciences"
- May 20 , 2005
Dr. Damon Demady (Biogen Idec) "Challenges of drug development: By the book vs. reality"
- April 22, 2005
Dr. Jinping Gan (Bristol-Myers Squibb) "Reactive metabolites in drug discovery"
- April 15, 2005
John Essigmann (MIT BE & CEHS) "De-mystification of the grant application process for new academic investigators"
- April 8, 2005
Nancy Briefs (President & CEO of Percardia) "A long winding road: From patent to PMA"
- March 25, 2005
Dr. Can Ozbal (BioTrove Inc.) "Mass spectroscopy-based label-free ultra-high throughput screening for drug discovery"
- March 11, 2005
Dr. Jonathan Gertler (Adams Harkness) "Market dynamics & financial strategies in life science technologies"
- February 25, 2005
Dr. Cindy Xia (Millenium) "From ABC to SLC: Evaluation of drug transporters in drug discovery and development"
- February 11, 2005
Dr. Keith Hoffmaster (Pfizer Inc.) "ADME in drug discovery & cholestasis as a mechanism of hepatotoxicity"
- December 13 , 2004
Drs. Birgit Schoeberl & Brian Harms (Merrimack Pharmaceuticals Inc.) "Starting a career in industry as an MIT alum"
- November 22, 2004
Dr. Vicki Sato (President of Vertex Pharmaceuticals Inc.) "Careers in academia & in industry"
- October 5, 2004 (see picture :))
Prof. Michael Lysaght (Brown University) "After the PhD: Career decisions in biomedical engineering"
